News

Pharmabiz1h

Gujarat FDCA receives Rs. 32 crore from state govt to expand Surat drug testing lab

Gujarat FDCA receives Rs. 32 crore from state govt to expand Surat drug testing lab: Shardul Nautiyal, Mumbai Thursday, ...
Pharmabiz30m

US FDA grants fast track designation to AAVantgarde Bio’s AAVB-039 to treat Stargardt disease

US FDA grants fast track designation to AAVantgarde Bio’s AAVB-039 to treat Stargardt disease: Milan Thursday, August 14, 2025, 09:00 Hrs [IST] AAVantgarde Bio (AAVantgarde), a ...
Pharmabiz1h

IPC 74th edition to chalk out next-gen pharma strategy in industry and education: Prof Milind Umekar

Nandita Vijayasimha, Bengaluru Thursday, August 14, 2025, 08:00 Hrs [IST] ...
Pharmabiz1h

Deadline extended for filing responses in anti-dumping probe on PNT imports from EU

Deadline extended for filing responses in anti-dumping probe on PNT imports from EU: Shardul Nautiyal, Mumbai Thursday, August 14, 2025, 08:00 Hrs [IST] The Directorate General of ...
Pharmabiz1h

Ayush ministry & FSSAI jointly release official list of approved "Ayurveda Ahar" products

Ayush ministry & FSSAI jointly release official list of approved "Ayurveda Ahar" products: Peethaambaran Kunnathoor, Chennai Thursday, August 14, 2025, 08:00 Hrs [IST] In a signif ...
Pharmabiz1h

CDSCO issues draft standards for IVD medical devices evaluation protocol

CDSCO issues draft standards for IVD medical devices evaluation protocol: Gireesh Babu, New Delhi Thursday, August 14, 2025, 08:00 Hrs [IST] The Central Drugs Standard Control Org ...
Pharmabiz19h

Indoco Remedies receives US FDA final approval for rivaroxaban tablets USP, 2.5 mg, 10 mg, 15 mg and 20 mg

Indoco Remedies receives US FDA final approval for rivaroxaban tablets USP, 2.5 mg, 10 mg, 15 mg and 20 mg: Our Bureau, Mumbai Wednesday, August 13, 2025, 13:45 Hrs [IST] Indoco R ...
Pharmabiz15h

Abcentra begins patient dosing in phase 2b FORTIFY trial evaluating orticumab in patients with cardiovascular disease

Abcentra begins patient dosing in phase 2b FORTIFY trial evaluating orticumab in patients with cardiovascular disease: Los Angeles Wednesday, August 13, 2025, 18:00 Hrs [IST] Abce ...
Pharmabiz18h

Biogen and Stoke Therapeutics dose first patient in global phase 3 EMPEROR study of zorevunersen to treat Dravet syndrome

Cambridge, Massachusetts Wednesday, August 13, 2025, 15:00 Hrs [IST] ...
Pharmabiz19h

STEER World with its 200 kg/hr continuous granulation using patented INTEGRAAL system to accelerate pharm manufacturing

STEER World with its 200 kg/hr continuous granulation using patented INTEGRAAL system to accelerate pharm manufacturing: Our Bureau, Bengaluru Wednesday, August 13, 2025, 14:30 Hr ...
Pharmabiz19h

Cohance Lifesciences pumps in Rs. 230 mn to progress on its cGMP oligonucleotide unit at Hyderabad

Cohance Lifesciences pumps in Rs. 230 mn to progress on its cGMP oligonucleotide unit at Hyderabad: Our Bureau, Bengaluru Wednesday, August 13, 2025, 14:15 Hrs [IST] Cohance Lifes ...
Pharmabiz18h

The 74th IPC’s official information brochure launched, signalling start of event's promotional and outreach activities

The 74th IPC’s official information brochure launched, signalling start of event's promotional and outreach activities: Our Bureau, Bengaluru Wednesday, August 13, 2025, 15:15 H ...